Literature DB >> 28697633

Zinc L-carnosine suppresses inflammatory responses in lipopolysaccharide-induced RAW 264.7 murine macrophages cell line via activation of Nrf2/HO-1 signaling pathway.

Theng Choon Ooi1, Kok Meng Chan2, Razinah Sharif3.   

Abstract

CONTEXT: Zinc L-carnosine (ZnC) is a chelate of Zn and L-carnosine and is used clinically in the treatment of peptic ulcer.
OBJECTIVE: In this study, we aim to investigate the involvement of heme oxygenase-1 (HO-1) in the anti-inflammatory effects of ZnC in lipopolysaccharide (LPS)-induced RAW 264.7 murine macrophages.
MATERIALS AND METHODS: We used immunoblotting analysis to evaluate the involvement of HO-1 in the anti-inflammatory effects of ZnC and the signaling pathway involved was measured using Dual luciferase reporter assay.
RESULTS: Results from immunoblotting analysis demonstrated that pretreatment of cells with ZnC enhanced the expression of HO-1 in RAW 264.7 cells. Pretreatment of cells with HO-1 inhibitor (tin protoporphyrin IX dichloride) significantly attenuated the inhibitory effects of ZnC on nitric oxide (NO) production, inducible nitric oxide synthase (iNOS) expression and NF-κB activation in LPS-induced RAW 264.7 cells, suggesting that HO-1 play an important role in the suppression of inflammatory responses induced by ZnC. Furthermore, results from co-immunoprecipitation of Nrf2 and Keap1 and dual luciferase reporter assay showed that pretreatment of ZnC was able to activate the Nrf2 signaling pathway. Treatment of cells with p38 inhibitor (SB203580), c-Jun N-terminal kinase inhibitor (SP600125), and MEK 1/2 inhibitor (U0126) did not significantly suppress the induction of HO-1 by ZnC. Moreover, our present findings suggest that the effects of ZnC on NO production, HO-1 expression, and Nrf2 activation were attributed to its Zn subcomponent, but not l-carnosine.
CONCLUSION: Pretreatment with ZnC was able to activate Nrf2/HO-1 signaling pathway, thus suppressing the expression of inflammatory mediators, such as NO and iNOS in LPS-induced RAW 264.7 cells.

Entities:  

Keywords:  Anti-inflammatory; Nrf2; RAW 264.7 cells; heme oxygenase-1; zinc L-carnosine

Mesh:

Substances:

Year:  2017        PMID: 28697633     DOI: 10.1080/08923973.2017.1344987

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  6 in total

1.  Deoxynivalenol-induced alterations in the redox status of HepG2 cells: identification of lipid hydroperoxides, the role of Nrf2-Keap1 signaling, and protective effects of zinc.

Authors:  Wageh Sobhy Darwish; Zhen Chen; Yonghan Li; Hui Tan; Hitoshi Chiba; Shu-Ping Hui
Journal:  Mycotoxin Res       Date:  2020-02-19       Impact factor: 3.833

2.  Carnosine Alleviates Knee Osteoarthritis and Promotes Synoviocyte Protection via Activating the Nrf2/HO-1 Signaling Pathway: An In-Vivo and In-Vitro Study.

Authors:  Prabhakar Busa; Sing-Ong Lee; Niancih Huang; Yaswanth Kuthati; Chih-Shung Wong
Journal:  Antioxidants (Basel)       Date:  2022-06-20

3.  (E)-N-(2-(3, 5-Dimethoxystyryl) phenyl) furan-2-carboxamide (BK3C231) induces cytoprotection in CCD18-Co human colon fibroblast cells through Nrf2/ARE pathway activation.

Authors:  Huan Huan Tan; Noel Francis Thomas; Salmaan Hussain Inayat-Hussain; Kok Meng Chan
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.379

4.  Study on the Local Anti-Osteoporosis Effect of Polaprezinc-Loaded Antioxidant Electrospun Membrane.

Authors:  Xue Gao; Mohammed A Al-Baadani; Minjie Wu; Ningyang Tong; Xinkun Shen; Xi Ding; Jinsong Liu
Journal:  Int J Nanomedicine       Date:  2022-01-04

5.  The Prevention and Management of COVID-19: Seeking a Practical and Timely Solution.

Authors:  Charulata Jindal; Sandeep Kumar; Sunil Sharma; Yuk Ming Choi; Jimmy T Efird
Journal:  Int J Environ Res Public Health       Date:  2020-06-04       Impact factor: 3.390

Review 6.  The KEAP1-NRF2 System in Healthy Aging and Longevity.

Authors:  Daisuke Matsumaru; Hozumi Motohashi
Journal:  Antioxidants (Basel)       Date:  2021-11-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.